Granada analyzes the impact of PERTE for Cutting-Edge Health in biomedical research
Researchers, institutions and companies are addressing the development of new therapies, diagnostic technologies and health innovation projects at this conference held at the Andalusian School of Public Health.
The PERTE for Cutting-Edge Health is a major investment and reform program by the Spanish Government in the health sector, supported by European funds from the Recovery, Transformation and Resilience Plan, which is turning our country into an international benchmark in science, innovation and digital technologies applied to health, around a much more cohesive ecosystem.
Granada hosted the conference “Impact of PERTE for Cutting-Edge Health in Granada”, an event organized by the Granada Institute of Biomedical Research (ibs.GRANADA) in collaboration with the PERTE Cutting-Edge Health Commissioner of the Ministry of Science, Innovation and Universities, which brought together institutional representatives, researchers and companies to analyze the development of scientific and technological projects linked to this strategic initiative of the Government of Spain.
The event included an institutional opening with the participation of representatives from the Ministry of Science, Innovation and Universities, the Carlos III Health Institute, the Andalusian Regional Government, the University of Granada and the main health and scientific institutions in the territory.
During her presentation, the scientific director of ibs.GRANADA, Dr. María José Sánchez, highlighted the importance of these types of initiatives in promoting biomedical research and strengthening collaboration between scientific institutions, hospitals, and companies. “The PERTE for Cutting-Edge Health program represents an opportunity to strengthen translational biomedical research and foster collaboration among different actors in the R&D&I system. These initiatives help ensure that scientific advances can be progressively translated into clinical practice and the healthcare system,” she noted.
For her part, Dr. Raquel Yotti, Commissioner of the PERTE program for Cutting-Edge Health at the Ministry of Science, Innovation and Universities, highlighted the high scientific level of the biomedical research projects developed in Granada and reiterated the Spanish Government's commitment to continue promoting science, innovation, and digital technologies that improve people's health and generate opportunities for economic growth. “The projects presented today in Granada demonstrate that through science and innovation we can drive a profound transformation of the healthcare system, based on prevention, early diagnosis, more precise treatments, and the intelligent use of data. The Spanish Government will continue to support science and innovation in service of health, in service of people.”
The Government Delegate, Antonio Granados, stated that the Andalusian Regional Government “is fully aware of the strategic importance of the health sector and the role it can play in the economic and social transformation of our region. Therefore, we are working to strengthen the healthcare system, promote biomedical research, and foster collaborative environments where talent, knowledge, and entrepreneurship can translate into innovation, skilled employment, and development.”
During her speech, she emphasized that “our commitment is to continue supporting initiatives that allow us to take advantage of opportunities such as the PERTE for Cutting-Edge Health and consolidate Andalusia, and Granada in particular, as a benchmark in research, health innovation and knowledge transfer” and added that “from the Regional Government we will continue to promote this type of initiative to identify strategic projects, channel investments and turn the potential of our health and scientific ecosystem into real advances that improve people's lives and contribute to the progress of Andalusia.”
The day included several working groups dedicated to the impact of PERTE in the scientific and technological fields. The first of these specifically addressed the impact of this initiative on ibs.GRANADA, with the participation of the Director General of the Carlos III Health Institute, Dr. Marina Pollán, and the Scientific Director of the Granada institute.
Subsequently, the meeting hosted a panel discussion on science, innovation and collaboration to improve health, in which researchers from ibs.GRANADA, the University of Granada, university hospitals and biotechnology companies presented various research and development projects.
Among the initiatives presented are projects related to new technologies for cancer detection, the development of advanced cell therapies, the use of nanoparticles with therapeutic potential, digital tools for diagnosis, and technological systems to improve the evaluation and rehabilitation of musculoskeletal injuries.
Also during the day, projects in the field of biofabrication and regenerative medicine were presented, such as the development of artificial cornea models for the treatment of severe corneal ulcers or new bioengineering strategies aimed at the repair of neural tissue.
The meeting highlighted the importance of collaboration between research centers, hospitals, universities, and companies as a key element in promoting innovation in health and facilitating the transfer of knowledge to the healthcare system.
The day concluded with an institutional closing ceremony in which the scientific leaders highlighted the role of PERTE for Cutting-Edge Health as an instrument to promote biomedical research and foster the development of new technologies and therapies aimed at improving the prevention, diagnosis and treatment of diseases.
About the ibs.GRANADA
The ibs.GRANADA Biomedical Research Institute, managed by the Alejandro Otero Foundation for Biomedical Research in Eastern Andalusia (FIBAO), is the only center accredited by the Carlos III Health Institute (ISCIII) that conducts cutting-edge biomedical research in Granada and one of only four accredited health research institutes in Andalusia. The institute comprises more than 1.213 professionals and 69 multidisciplinary groups from the University of Granada, the Virgen de las Nieves University Hospital, the San Cecilio University Clinical Hospital, the Andalusian School of Public Health, and primary care centers in Granada.
Its scientific activity is organized into four areas: Oncology, Precision Medicine, Epidemiology and Public Health, and Advanced Technology and Therapies. In 2024, the institute produced 1.063 scientific publications with a total impact factor of 6.528 and filed 23 patent applications, reflecting its commitment to generating knowledge and transferring scientific advances to the prevention, diagnosis, and treatment of major health problems.
More information: www.ibsgranada.es
